Timolol and Psoriasis aggravated - a phase IV clinical study of FDA data

Summary:

Psoriasis aggravated is reported as a side effect among people who take Timolol (timolol), especially for people who are male, 60+ old, also take Folic Acid, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Psoriasis aggravated when taking Timolol. It is created by eHealthMe based on reports of 9,083 people who have side effects when taking Timolol from the FDA, and is updated regularly.

What is Timolol?

Timolol has active ingredients of timolol. It is often used in glaucoma. eHealthMe is studying from 9,142 Timolol users. Check the latest studies of Timolol.

What is Psoriasis aggravated?

Psoriasis aggravated (immune-mediated disease that affects the skin) is found to be associated with 1,285 drugs and 472 conditions by eHealthMe. Check the latest studies of Psoriasis aggravated.

On Jul, 14, 2026

9,083 people reported to have side effects when taking Timolol.
Among them, 35 people (0.39%) have Psoriasis aggravated.

Could Timolol cause Psoriasis aggravated?

Among these 35 people:

What is the gender of people who have Psoriasis aggravated when taking Timolol? *

female: 50 %
male: 50 %

What is the age of people who have Psoriasis aggravated when taking Timolol? *

What are other drugs people take besides Timolol? *

What are other side effects people have besides Psoriasis aggravated? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 17.14%
Drug Ineffective: 6 people, 17.14%
Joint Pain: 5 people, 14.29%
Acute Kidney Failure: 5 people, 14.29%
C-Reactive Protein Increased: 5 people, 14.29%
Nephropathy (damage to or disease of a kidney): 5 people, 14.29%
Pain In Extremity: 5 people, 14.29%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 5 people, 14.29%
Back Pain: 4 people, 11.43%
Injection Site Bruising: 4 people, 11.43%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 10 people, 28.57%
High Blood Pressure: 3 people, 8.57%
Depression: 2 people, 5.71%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 5.71%
Diabetes: 2 people, 5.71%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 5.71%
High Blood Cholesterol: 2 people, 5.71%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.71%
Skin Disorder (skin disease): 2 people, 5.71%
Corneal Disorder: 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Timolol and have Psoriasis aggravated?

- Check whether Psoriasis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Timolol:

Timolol (9,142 reports)

Browse all side effects of Timolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Psoriasis aggravated:

Psoriasis aggravated (1,286 drugs)

Browse all the conditions that are associated with Psoriasis aggravated:

Psoriasis aggravated (472 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on timolol (the active ingredients of Timolol) and Timolol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.